Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Rheumatology (Oxford, England)
|
December 6, 2003
The impact of escalating conventional therapy in rheumatoid arthritis patients referred for anti-tumour necrosis factor-alpha therapy
S J Bingham, M H Buch, A Tennant, et al.
Rheumatology (Oxford, England)
|
May 5, 2007
Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders
M H Buch, S J Bingham, D Bryer, et al.
Clinical and Experimental Rheumatology
|
July 17, 2009
Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire
G H Ibrahim, M H Buch, C Lawson, et al.
Annals of the Rheumatic Diseases
|
March 23, 2004
True infliximab resistance in rheumatoid arthritis: a role for lymphotoxin alpha?
M H Buch, P G Conaghan, M A Quinn, et al.
Annals of the Rheumatic Diseases
|
May 24, 2014
What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort
K Takase, S C Horton, A Ganesha, et al.
Arthritis and Rheumatism
|
February 5, 2010
Management of nonresponse to rituximab in rheumatoid arthritis: predictors and outcome of re-treatment
E M Vital, S Dass, A C Rawstron, et al.
Arthritis Research & Therapy
|
December 24, 2017
Profiling microRNAs in individuals at risk of progression to rheumatoid arthritis
L Ouboussad, L Hunt, E M A Hensor, et al.
Rheumatology (Oxford, England)
|
July 29, 2008
The value of synovial cytokine expression in predicting the clinical response to TNF antagonist therapy (infliximab)
M H Buch, R J Reece, M A Quinn, et al.
Annals of the Rheumatic Diseases
|
April 7, 2009
Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level
E Jones, S M Churchman, A English, et al.
Annals of the Rheumatic Diseases
|
May 8, 2010
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
J L Nam, K L Winthrop, R F van Vollenhoven, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Rheumatology (Oxford, England)
|
December 6, 2003
The impact of escalating conventional therapy in rheumatoid arthritis patients referred for anti-tumour necrosis factor-alpha therapy
S J Bingham, M H Buch, A Tennant, et al.
Rheumatology (Oxford, England)
|
May 5, 2007
Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders
M H Buch, S J Bingham, D Bryer, et al.
Clinical and Experimental Rheumatology
|
July 17, 2009
Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire
G H Ibrahim, M H Buch, C Lawson, et al.
Annals of the Rheumatic Diseases
|
March 23, 2004
True infliximab resistance in rheumatoid arthritis: a role for lymphotoxin alpha?
M H Buch, P G Conaghan, M A Quinn, et al.
Annals of the Rheumatic Diseases
|
May 24, 2014
What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort
K Takase, S C Horton, A Ganesha, et al.
Arthritis and Rheumatism
|
February 5, 2010
Management of nonresponse to rituximab in rheumatoid arthritis: predictors and outcome of re-treatment
E M Vital, S Dass, A C Rawstron, et al.
Arthritis Research & Therapy
|
December 24, 2017
Profiling microRNAs in individuals at risk of progression to rheumatoid arthritis
L Ouboussad, L Hunt, E M A Hensor, et al.
Rheumatology (Oxford, England)
|
July 29, 2008
The value of synovial cytokine expression in predicting the clinical response to TNF antagonist therapy (infliximab)
M H Buch, R J Reece, M A Quinn, et al.
Annals of the Rheumatic Diseases
|
April 7, 2009
Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level
E Jones, S M Churchman, A English, et al.
Annals of the Rheumatic Diseases
|
May 8, 2010
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
J L Nam, K L Winthrop, R F van Vollenhoven, et al.
Page
of 2